|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities | |||||
| (Loss) income before tax | |||||
| Income tax paid | |||||
| Payment of contingent consideration in relation to business combinations | |||||
| Payment of deferred consideration in relation to business combinations | |||||
| Other | |||||
| Adjustments for non-cash items: | |||||
| Depreciation and amortization | |||||
| Net finance expense | |||||
| Movements in credit loss allowance and write-offs | |||||
| Fair value movement on contingent consideration | |||||
| Impairment loss on intangible assets | |||||
| Share-based payment expense | |||||
| Warrants repurchased | |||||
| Cash flows from operating activities before changes in working capital | |||||
| Changes in working capital | |||||
| Trade and other receivables | |||||
| Trade and other payables | |||||
| Inventories | |||||
| Cash flows generated by operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of property and equipment | |||||
| Acquisition of intangible assets | |||||
| Capitalization of internally developed intangibles | |||||
| Acquisition of subsidiaries, net of cash acquired | |||||
| Interest received from bank deposits | |||||
| Payment of deferred consideration in relation to asset acquisitions and business combinations | |||||
| Payment of deferred consideration for intangible assets | |||||
| Payment of contingent consideration in relation to business combinations | |||||
| Cash flows used in investing activities | |||||
| Cash flows from financing activities | |||||
| Exercise of options | |||||
| Issue of ordinary shares in relation to employee stock purchase plan | |||||
| Equity issue costs | |||||
| Interest payment attributable to deferred consideration settled | |||||
| Treasury shares acquired | |||||
| Proceeds from borrowings | |||||
| Transaction costs related to borrowings | |||||
| Repayment of borrowings | |||||
| Repayment of debt assumed in a business combination | |||||
| Repayment of other non-current liability assumed in a business combination | |||||
| Principal proceeds from the settlements of the derivative financial instrument used to hedge liabilities arising from financing activities | |||||
| Interest proceeds from the settlements of the derivative financial instrument used to hedge liabilities arising from financing activities | |||||
| Principal payment of settlements of the derivative financial instrument used to hedge liabilities arising from financing activities | |||||
| Interest payment of settlements of the derivative financial instrument used to hedge liabilities arising from financing activities | |||||
| Interest payment attributable to third party borrowings | |||||
| Interest payment attributable to deferred consideration settled in relation to business combinations | |||||
| Interest payment attributable to deferred consideration settled for intangible assets | |||||
| Principal paid on lease liability | |||||
| Interest paid on lease liability | |||||
| Cash flows generated from (used in) financing activities | |||||
| Net movement in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Net foreign exchange differences on cash and cash equivalents | |||||
| Cash and cash equivalents at the end of the year | |||||
| Supplemental non-cash items | |||||
| Right-of-use assets | |||||
| Issue of ordinary shares for acquisitions | |||||
| Issue of ordinary shares in relation to employee stock purchase plan | |||||
Loading...